Variation in uptake and dose reduction of CDK4/6 inhibitors for the treatment of breast cancer in England, 2019–2024: a descriptive observational study using OpenPrescribing Hospitals

Fisher L, Polwart C, Wood C, Goldacre B, Anderson L, Isherwood J, Hindocha S, MacKenna B, Speed V.

DOI: 10.64898/2026.08.05.26359678
Published: 2026-08-10
Container: Not recorded
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 41/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.08.05.26359678,
  title = {Variation in uptake and dose reduction of CDK4/6 inhibitors for the treatment of breast cancer in England, 2019–2024: a descriptive observational study using OpenPrescribing Hospitals},
  author = {Fisher L and  Polwart C and  Wood C and  Goldacre B and  Anderson L and  Isherwood J and  Hindocha S and  MacKenna B and  Speed V.},
  year = {2026},
  doi = {10.64898/2026.08.05.26359678},
  url = {https://doi.org/10.64898/2026.08.05.26359678}
}

RIS

TY  - JOUR
TI  - Variation in uptake and dose reduction of CDK4/6 inhibitors for the treatment of breast cancer in England, 2019–2024: a descriptive observational study using OpenPrescribing Hospitals
AU  - Fisher L
AU  -  Polwart C
AU  -  Wood C
AU  -  Goldacre B
AU  -  Anderson L
AU  -  Isherwood J
AU  -  Hindocha S
AU  -  MacKenna B
AU  -  Speed V.
PY  - 2026
DO  - 10.64898/2026.08.05.26359678
UR  - https://doi.org/10.64898/2026.08.05.26359678
ER  -

APA

L, F., C, P., C, W., B, G., L, A., J, I., S, H., B, M., & V., S. (2026). Variation in uptake and dose reduction of CDK4/6 inhibitors for the treatment of breast cancer in England, 2019–2024: a descriptive observational study using OpenPrescribing Hospitals. https://doi.org/10.64898/2026.08.05.26359678

Source records

europe-pmc · retrieved 2026-09-25T07:49:52.823Z